University of Miami's 2nd Biennial Miami Leukemia Symposium

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

2020 Update on Ph- MPN: What Are the Potential Benefits and Limitations to JAKi? Which Alternative Pathogenetic Mechanisms Can Improve Therapeutic Benefit?

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Olatoyosi Odenike
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Olatoyosi Odenike
166 views
October 23, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
CML and MPNs: Final Frontiers and New Breakthroughs
21:24

2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benefit t…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Tyner

37 views
26:24

2020 Update on CML: What Strategies Can Help Overcome Multi-TKI Resi…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Cortés

153 views
25:18

2020 Update on Ph- MPN: What Are the Potential Benefits and Limitati…

University of Miami's 2nd Biennial Miami Leukemia Symposium

O. Odenike

166 views
21:19

2020 Update on BPDCN: Efficacy Analysis of Available Standard Therap…

University of Miami's 2nd Biennial Miami Leukemia Symposium

N. Pemmaraju

19 views